Black Diamond Therapeutics Inc (BDTX)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -114.749 | -29.846 | -33.56 | -27.565 | -43.508 | -45.14 | -52.374 |
Return on Equity (%) | 137.888 | 80.398 | 112.468 | -51.615 | -49.874 | -58.518 | -70.939 |
Return on Invested Capital (%) | -142.575 | -34.919 | -29.897 | -30.418 | -53.602 | -67.555 | -75.039 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.882 | 6.755 | 68.581 | 8.53 | 5.407 | 3.175 | 2.261 |
Earnings Per Share | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
Cash Per Share | 1.202 | 7.716 | 69.14 | 0.959 | 1.816 | 0.942 | 1.089 |
Working Capital Per Share | 0.867 | 7.335 | 67.435 | 8.463 | 5.301 | 3.086 | 2.215 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
EBITDA Per Share | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
Free Cash Flow Per Share | -0.694 | -1.329 | -15.773 | -1.862 | -3.397 | -2.511 | -1.604 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 6.56M | 6.7M | 2.24M | 36.08M | 36.23M | 36.43M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 36.43M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 119.39M |
Price to Earnings Ratio | -1.45 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.12 |
Price to Book Ratio | 1.02 |
Dividend Yield | - |
Shares Outstanding | 56.59M |
Average Volume (1 week) | 3.83M |
Average Volume (1 Month) | 1.24M |
52 Week Change | -28.96% |
52 Week High | 7.66 |
52 Week Low | 1.91 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.